Reuters logo
BRIEF-Intra-Cellular therapies reports Q1 loss per share $0.62
May 10, 2017 / 11:54 AM / in 5 months

BRIEF-Intra-Cellular therapies reports Q1 loss per share $0.62

May 10 (Reuters) - Intra-cellular Therapies Inc:

* Intra-Cellular therapies reports first quarter 2017 financial results and provides corporate update

* Q1 loss per share $0.62

* Q1 earnings per share view $-0.72 -- Thomson Reuters I/B/E/S

* research and development (research and development) expenses for Q1 of 2017 were $21.5 million, compared to $23.4 million for Q1 of 2016

* Intra-Cellular Therapies- cash, cash equivalents and investment securities totaled $367.8 million at march 31, 2017, compared to $384.1 million at December 31, 2016

* Qtrly revenues $95,287 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below